{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:36:34Z","timestamp":1772192194268,"version":"3.50.1"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T00:00:00Z","timestamp":1413763200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0110306","type":"journal-article","created":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T18:08:01Z","timestamp":1413828481000},"page":"e110306","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["MEK Inhibitors, Novel Anti-Adhesive Molecules, Reduce Sickle Red Blood Cell Adhesion In Vitro and In Vivo, and Vasoocclusion In Vivo"],"prefix":"10.1371","volume":"9","author":[{"given":"Rahima","family":"Zennadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,10,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/cts.12005","article-title":"Effect of propranolol as antiadhesive therapy in sickle cell disease","volume":"5","author":"LM De Castro","year":"2012","journal-title":"Clin Transl Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM198005013021803","article-title":"Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity","volume":"302","author":"RP Hebbel","year":"1980","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood.V97.7.1937","article-title":"Modulation of endothelial cell activation in sickle cell disease: a pilot study","volume":"97","author":"AA Solovey","year":"2001","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tracli.2008.03.011","article-title":"Adhesion of sickle red cells to endothelium: myths and future directions","volume":"15","author":"RP Hebbel","year":"2008","journal-title":"Transfus Clin Biol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3324\/haematol.2010.028506","article-title":"Abnormal modulation of cell protective systems in response to ischemic\/reperfusion injury is important in the development of mouse sickle cell hepatopathy","volume":"96","author":"A Siciliano","year":"2011","journal-title":"Haematologica"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1172\/JCI33308","article-title":"Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease","volume":"118","author":"N Sabaa","year":"2008","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood.V79.8.2154.2154","article-title":"Red blood cell changes during the evolution of the sickle cell painful crisis","volume":"79","author":"SK Ballas","year":"1992","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood.V68.1.301.301","article-title":"The percentage of dense red cells does not predict incidence of sickle cell painful crisis","volume":"68","author":"HH Billett","year":"1986","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1182\/blood.V83.10.3006.3006","article-title":"Adhesion of sickle cells to vascular endothelium is critically dependent on changes in density and shape of the cells","volume":"83","author":"DK Kaul","year":"1994","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood.V68.5.1162.1162","article-title":"Vaso-occlusion by sickle cells: evidence for selective trapping of dense red cells","volume":"68","author":"DK Kaul","year":"1986","journal-title":"Blood"},{"key":"ref11","first-page":"706","article-title":"Red cell distribution width parallels dense red cell disappearance during painful crises in sickle cell anemia","volume":"105","author":"C Lawrence","year":"1985","journal-title":"J Lab Clin Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.286.17.2099","article-title":"Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial","volume":"286","author":"EP Orringer","year":"2001","journal-title":"JAMA"},{"key":"ref13","first-page":"3281","article-title":"Blood","volume":"101","author":"PC Hines","year":"2003"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1182\/blood-2004-01-0042","article-title":"Epinephrine acts through erythroid signaling pathways to activate sickle cell adhesion to endothelium via LW-alphavbeta3 interactions","volume":"104","author":"R Zennadi","year":"2004","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.trsl.2008.07.007","article-title":"Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin-binding domain","volume":"152","author":"S Gayen Betal","year":"2008","journal-title":"Transl Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1182\/blood-2008-01-134346","article-title":"Sickle red cells induce adhesion of lymphocytes and monocytes to endothelium","volume":"112","author":"R Zennadi","year":"2008","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2006-11-056101","article-title":"Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo","volume":"110","author":"R Zennadi","year":"2007","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood-2011-03-344440","article-title":"Erythrocyte plasma membrane-bound ERK1\/2 activation promotes ICAM-4-mediated sickle red cell adhesion to endothelium","volume":"119","author":"R Zennadi","year":"2012","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.2011.0030","article-title":"Cytokine levels and profiles in children related to sickle cell disease and asthma status","volume":"32","author":"J Knight-Madden","year":"2012","journal-title":"J Interferon Cytokine Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/CVI.00145-09","article-title":"Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis","volume":"17","author":"BO Musa","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1076029611420992","article-title":"Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease","volume":"18","author":"MH Qari","year":"2012","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref22","unstructured":"Iverson C, Chapman MS, Clendeninn N, Girardet J, Sheedy B, <etal>et al<\/etal>.. (2008) The effect of MEK inhibitor RDEA119 on biomarkers in advanced cancer patients in a phase I clinical trial. Molecular Markers (Abstract)."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1158\/0008-5472.CAN-09-0679","article-title":"RDEA119\/BAY 869766: a potent, selective, allosteric inhibitor of MEK1\/2 for the treatment of cancer","volume":"69","author":"C Iverson","year":"2009","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1470-2045(12)70270-X","article-title":"Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial","volume":"13","author":"JR Infante","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/1078-0432.CCR-10-2200","article-title":"GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition","volume":"17","author":"AG Gilmartin","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/mvre.1993.1018","article-title":"Evaluation of carbocyanine-labeled erythrocytes for microvascular measurements","volume":"45","author":"JL Unthank","year":"1993","journal-title":"Microvasc Res"},{"key":"ref27","unstructured":"Algire GH, Legallais FY (1949) Recent developments in the transparent-chamber technique as adapted to the mouse. J Natl Cancer Inst 10: 225\u2013253, incl 228 pl."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajh.20143","article-title":"Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy","volume":"77","author":"VS Kalambur","year":"2004","journal-title":"Am J Hematol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1155\/2002\/820102","article-title":"Intravital fluorescence facilitates measurement of multiple physiologic functions and gene expression in tumors of live animals","volume":"18","author":"MW Dewhirst","year":"2002","journal-title":"Dis Markers"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.052522799","article-title":"Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm","volume":"99","author":"A Turhan","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.21928","article-title":"Severe sickle cell anemia is associated with increased plasma levels of TNF-R1 and VCAM-1","volume":"86","author":"DA Dworkis","year":"2011","journal-title":"Am J Hematol"},{"key":"ref32","first-page":"863","article-title":"Childhood sickle cell crises: clinical severity, inflammatory markers and the role of interleukin-8","volume":"89","author":"M Etienne-Julan","year":"2004","journal-title":"Haematologica"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood.V96.7.2451","article-title":"Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion","volume":"96","author":"JD Belcher","year":"2000","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"12404","DOI":"10.1021\/bi00038a038","article-title":"Damnacanthal is a highly potent, selective inhibitor of p56lck tyrosine kinase activity","volume":"34","author":"CR Faltynek","year":"1995","journal-title":"Biochemistry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jlb.66.3.411","article-title":"Neutrophil activation in sickle cell disease","volume":"66","author":"LR Lard","year":"1999","journal-title":"J Leukoc Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/10245332.2000.11746536","article-title":"The Role of Inflammation and Leukocytes in the Pathogenesis of Sickle Cell Disease; Haemoglobinopathy","volume":"5","author":"T Wun","year":"2001","journal-title":"Hematology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1023\/B:ABME.0000030256.37022.02","article-title":"The effect of hematocrit and leukocyte adherence on flow direction in the microcirculation","volume":"32","author":"MR King","year":"2004","journal-title":"Ann Biomed Eng"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.annemergmed.2011.11.026","article-title":"What is the best pharmacologic treatment for sickle cell disease pain crises?","volume":"59","author":"M Baker","year":"2012","journal-title":"Ann Emerg Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2012-04-383430","article-title":"Sickle cell pain: a critical reappraisal","volume":"120","author":"SK Ballas","year":"2012","journal-title":"Blood"},{"key":"ref40","first-page":"348","article-title":"Established and experimental treatments for sickle cell disease","volume":"89","author":"L De Franceschi","year":"2004","journal-title":"Haematologica"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0026-2862(87)90050-1","article-title":"Flow dynamics of human sickle erythrocytes in the mesenteric microcirculation of the exchange-transfused rat","volume":"34","author":"J Kurantsin-Mills","year":"1987","journal-title":"Microvasc Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1161\/CIRCULATIONAHA.104.485029","article-title":"Noninvasive imaging of angiogenesis with a 99mTc-labeled peptide targeted at alphavbeta3 integrin after murine hindlimb ischemia","volume":"111","author":"J Hua","year":"2005","journal-title":"Circulation"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1167\/iovs.05-1314","article-title":"SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity","volume":"47","author":"JL Wilkinson-Berka","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1182\/blood.V91.1.266","article-title":"Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64","volume":"91","author":"E Fadlon","year":"1998","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1182\/blood.V92.10.3924","article-title":"Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes","volume":"92","author":"C Sultana","year":"1998","journal-title":"Blood"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"H379","DOI":"10.1152\/ajpheart.01068.2007","article-title":"Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium","volume":"294","author":"J Haynes Jr","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"H1679","DOI":"10.1152\/ajpheart.00256.2006","article-title":"Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells","volume":"291","author":"J Haynes Jr","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/mic.11.2.129.151","article-title":"The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy","volume":"11","author":"RP Hebbel","year":"2004","journal-title":"Microcirculation"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mlc.2001.115450","article-title":"Thrombogenesis in sickle cell disease","volume":"137","author":"A Tomer","year":"2001","journal-title":"J Lab Clin Med"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Ataga KI, Key NS (2007) Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program: 91\u201396.","DOI":"10.1182\/asheducation-2007.1.91"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.ATV.0000220374.00602.a2","article-title":"Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation","volume":"26","author":"SP Lee","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MOH.0b013e328363442f","article-title":"Hemostatic abnormalities in sickle cell disease","volume":"20","author":"MY Lim","year":"2013","journal-title":"Curr Opin Hematol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0110306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T20:04:15Z","timestamp":1598385855000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0110306"}},"subtitle":[],"editor":[{"given":"Ronald J.","family":"Korthuis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,20]]},"references-count":52,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0110306","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.723347235.793510072","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,20]]}}}